Clinical Trials Directory

Trials / Completed

CompletedNCT01008631

The Pharmacologic Profile of Sodium Thiosulfate in Renal Failure and Healthy Volunteers

The Pharmacologic Profile of Sodium Thiosulfate in Renal Failure and Healthy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

The pharmacokinetics of sodium thiosulfate in humans with different degrees of renal failure and in healthy volunteers will be after two single shot applications.

Detailed description

Two single shot applications of i.v. sodium thiosulfate will be given to dialysis patients. One application will be given immediately before a dialysis session and the second dose will be given after the consecutive dialysis session. In healthy volunteers sodium thiosulfate will be given only once. In both groups, dialysis patients and healthy volunteers, blood and urinary/dialysate samples will be collected at defined time points.

Conditions

Interventions

TypeNameDescription
DRUGSodium thiosulfate6g of Sodium Thiosulfate are applicated in a short infusion over a time of 5 min

Timeline

Start date
2009-09-01
Primary completion
2010-08-01
Completion
2010-08-01
First posted
2009-11-06
Last updated
2011-10-13

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01008631. Inclusion in this directory is not an endorsement.

The Pharmacologic Profile of Sodium Thiosulfate in Renal Failure and Healthy Volunteers (NCT01008631) · Clinical Trials Directory